A serotype-independent, broad spectrum pneumococcal vaccine

一种不依赖于血清型的广谱肺炎球菌疫苗

• 批准号: nhmrc : GNT1136903
• 负责人: Dr Mohammed Alsharifi
• 金额: $ 95.56万
• 依托单位国家: 澳大利亚
• 项目类别: Development Grants
• 财政年份: 2018
• 资助国家: 澳大利亚
• 起止时间: 2018-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/serotype-independent-broad-pneumococcal-vaccine/1348070
• 关键词: serotype; independent; broad; spectrum; pneumococcal

Streptococcus pneumoniae (the pneumococcus) is the world’s most formidable bacterial pathogen, causing 1-2 million deaths each year. Existing vaccines provide protection against only a limited proportion of strains and their widespread use is increasing the prevalence of strains against which the vaccines provide no protection. This project aims to translate a novel broadly protective pneumococcal vaccine into the commercial development pipeline.

肺炎链球菌（肺炎球菌）是世界上最可怕的细菌病原体，每年造成1- 200万人死亡。现有疫苗只能对有限比例的病毒株提供保护，而且疫苗的广泛使用正在增加疫苗无法提供保护的病毒株的流行。该项目旨在将一种新的广泛保护性肺炎球菌疫苗转化为商业开发管道。